APP and Alzheimer disease: Finally, the synthetic feasibility led us to combine 7‐MEOTA with p-anisidine, a commercially available chemical compound with a potential to decrease intracellular accumulation of amyloid precursor protein (APP), the precursor of neurotoxic Aβ found in the brains of AD patients (Figure 2) [30].